These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 3203335)
1. Modifying effects of concomitant treatment with butylated hydroxyanisole or butylated hydroxytoluene on N,N-dibutylnitrosamine-induced liver, forestomach and urinary bladder carcinogenesis in F344 male rats. Imaida K; Fukushima S; Inoue K; Masui T; Hirose M; Ito N Cancer Lett; 1988 Dec; 43(3):167-72. PubMed ID: 3203335 [TBL] [Abstract][Full Text] [Related]
2. Different modifying response of butylated hydroxyanisole, butylated hydroxytoluene, and other antioxidants in N,N-dibutylnitrosamine esophagus and forestomach carcinogenesis of rats. Fukushima S; Sakata T; Tagawa Y; Shibata MA; Hirose M; Ito N Cancer Res; 1987 Apr; 47(8):2113-6. PubMed ID: 3829000 [TBL] [Abstract][Full Text] [Related]
3. Promoting activities of butylated hydroxyanisole, butylated hydroxytoluene and sodium L-ascorbate on forestomach and urinary bladder carcinogenesis initiated with methylnitrosourea in F344 male rats. Imaida K; Fukushima S; Shirai T; Masui T; Ogiso T; Ito N Gan; 1984 Sep; 75(9):769-75. PubMed ID: 6500233 [TBL] [Abstract][Full Text] [Related]
4. Effects of butylated hydroxyanisole pretreatment on low dose N-methyl-N'-nitro-N-nitrosoguanidine- or N,N-dibutylnitrosamine-induced rat forestomach or esophageal carcinogenesis. Hirose M; Uwagawa S; Ozaki K; Takaba K; Ito N Carcinogenesis; 1991 Oct; 12(10):1773-6. PubMed ID: 1934256 [TBL] [Abstract][Full Text] [Related]
5. Effects of butylated hydroxyanisole, butylated hydroxytoluene, and NaCl on gastric carcinogenesis initiated with N-methyl-N'-nitro-N-nitrosoguanidine in F344 rats. Shirai T; Fukushima S; Ohshima M; Masuda A; Ito N J Natl Cancer Inst; 1984 May; 72(5):1189-98. PubMed ID: 6585594 [TBL] [Abstract][Full Text] [Related]
6. Modifying effects of simultaneous treatment with butylated hydroxyanisole (BHA) on rat tumor induction by 3,2'-dimethyl-4-aminobiphenyl, 2,2'-dihydroxy-di-n-propylnitrosamine and N-methylnitrosourea. Ito N; Hirose M; Shibata M; Tanaka H; Shirai T Carcinogenesis; 1989 Dec; 10(12):2255-9. PubMed ID: 2591015 [TBL] [Abstract][Full Text] [Related]
7. Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of gamma-glutamyl transpeptidase-positive foci development in the liver of rats. Imaida K; Fukushima S; Shirai T; Ohtani M; Nakanishi K; Ito N Carcinogenesis; 1983; 4(7):895-9. PubMed ID: 6135514 [TBL] [Abstract][Full Text] [Related]
8. Induction of tumors in the liver, urinary bladder, esophagus and forestomach by short-term treatment with different doses of N,N'-dibutylnitrosamine in rats. Tsuda H; Mera Y; Seki K; Aoki T; Fukushima S; Ito N Jpn J Cancer Res; 1987 Mar; 78(3):227-34. PubMed ID: 2883167 [TBL] [Abstract][Full Text] [Related]
9. Activation of N-ras gene in a rat hepatocellular carcinoma induced by dibutylnitrosamine and butylated hydroxytoluene. Funato T; Yokota J; Sakamoto H; Kameya T; Fukushima S; Ito N; Terada M; Sugimura T Jpn J Cancer Res; 1987 Jul; 78(7):689-94. PubMed ID: 3040652 [TBL] [Abstract][Full Text] [Related]
10. Effect of sodium phenobarbital and sodium saccharin in AIN-76A diet on carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and N,N-dibutylnitrosamine in male F344 rats. Imaida K; Wang CY Cancer Res; 1986 Dec; 46(12 Pt 1):6160-4. PubMed ID: 3779637 [TBL] [Abstract][Full Text] [Related]
11. Selective induction of rat urinary bladder tumors by simultaneous administration of 3,2'-dimethyl-4-aminobiphenyl (DMAB) and butylated hydroxyanisole or butylated hydroxytoluene is associated with increased DMAB-DNA adduct formation. Shirai T; Fukushima S; Kawabe M; Shibata M; Iwasaki S; Tada M; Ito N Carcinogenesis; 1991 Jul; 12(7):1335-9. PubMed ID: 1906380 [TBL] [Abstract][Full Text] [Related]
12. Carcinogenicity and modification of the carcinogenic response by BHA, BHT, and other antioxidants. Ito N; Fukushima S; Tsuda H Crit Rev Toxicol; 1985; 15(2):109-50. PubMed ID: 3899519 [TBL] [Abstract][Full Text] [Related]
13. Modification of carcinogenesis by antioxidants and other compounds. Tsuda H; Fukushima S; Imaida K; Sakata T; Ito N Acta Pharmacol Toxicol (Copenh); 1984; 55 Suppl 2():125-43. PubMed ID: 6148834 [TBL] [Abstract][Full Text] [Related]
14. Inhibition by dehydroepiandrosterone of butylated hydroxyanisole (BHA) promotion of rat-bladder carcinogenesis and enhancement of BHA-induced forestomach hyperplasia. Shibata MA; Shirai T; Asakawa E; Hirose M; Fukushima S Int J Cancer; 1993 Mar; 53(5):819-23. PubMed ID: 8449607 [TBL] [Abstract][Full Text] [Related]
15. Dose-dependent effects of butylated hydroxyanisole, butylated hydroxytoluene and ethoxyquin for promotion of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats. Fukushima S; Ogiso T; Kurata Y; Hirose M; Ito N Cancer Lett; 1987 Jan; 34(1):83-90. PubMed ID: 3802071 [TBL] [Abstract][Full Text] [Related]
16. Dose-related inhibition of aflatoxin B1 induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxyanisole and butylated hydroxytoluene. Williams GM; Tanaka T; Maeura Y Carcinogenesis; 1986 Jul; 7(7):1043-50. PubMed ID: 2872975 [TBL] [Abstract][Full Text] [Related]
17. Histologic and autoradiographic studies on the forestomach of hamsters treated with 2-tert-butylated hydroxyanisole, 3-tert-butylated hydroxyanisole, crude butylated hydroxyanisole, or butylated hydroxytoluene. Hirose M; Masuda A; Kurata Y; Ikawa E; Mera Y; Ito N J Natl Cancer Inst; 1986 Jan; 76(1):143-9. PubMed ID: 3455736 [TBL] [Abstract][Full Text] [Related]
18. Studies on antioxidants: their carcinogenic and modifying effects on chemical carcinogenesis. Ito N; Hirose M; Fukushima S; Tsuda H; Shirai T; Tatematsu M Food Chem Toxicol; 1986; 24(10-11):1071-82. PubMed ID: 3804112 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of antioxidants on N-bis(2-hydroxypropyl)nitrosamine-induced lung carcinogenesis in rats. Hasegawa R; Furukawa F; Toyoda K; Takahashi M; Hayashi Y; Hirose M; Ito N Jpn J Cancer Res; 1990 Sep; 81(9):871-7. PubMed ID: 2121688 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of the hepatocarcinogenicity of aflatoxin B1 in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene. Williams GM; Iatropoulos MJ Cancer Lett; 1996 Jun; 104(1):49-53. PubMed ID: 8640745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]